The US Food and Drug Administration will now require Covid-19 vaccines to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...

Vaccine expert Dr. Paul Offit delivered a graduation address to the next generation of doctors coming from University of ...

WASHINGTON (AP) — A government report released on Thursday covering wide swaths of American health and wellness reflects some ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...